NEW YORK (GenomeWeb) – The National Institutes of Health announced today that it has awarded more than $11 million in grant funding to support six research projects investigating various aspects of genomics and its role in human disease.

The awards were made as part of the NIH's High-Risk, High-Reward Research Program — a part of the agency's Common Fund designed to promote high-impact biomedical research — which has awarded approximately $127 million to fund 88 grants thus far.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.